Since receiving her doctorate in history and philosophy of science at the University of Pittsburgh, Kathryn Tabb has earned a master’s degree in bioethics and health law and served as assistant professor in the Department of Philosophy at Columbia University. Her interests include philosophy of science and medicine, bioethics, psychopathology, American pragmatism, and the history of philosophy, especially early modern philosophy. At Columbia, she taught courses at both the undergraduate and graduate levels, including Science and Values, The Normal and the Pathological, Darwin, and Contemporary Civilization. Professor Tabb is currently working on a monograph on John Locke, Agents and Patients: Locke’s Ethics of Thinking, that explores his theory of psychopathology and its implications for his philosophical theories. Recent peer-reviewed publications include the articles “Behavioral Genetics and Attributions of Moral Responsibility,” Behavioral Genetics; “Philosophy of Psychiatry after Diagnostic Kinds,” Synthese; “Locke on Enthusiasm and the Association of Ideas,” Oxford Studies in Early Modern Philosophy, Vol. 9; and “Darwin at Orchis Bank: Selection after the Origin,” Studies in History and Philosophy of Biological and Biomedical Sciences (2016). Her published work also includes reviews and commentary in Behavioral and Brain Sciences, Psychological Medicine, and Evolutionary Education and Outreach; and book chapters in Perspectives in Philosophy and Psychiatry IV: Psychiatric Nosology; Perspectives in Philosophy and Psychiatry III: The Nature and Sources of Historical Change; and Brain, Mind, and Consciousness in the History of Neuroscience. She is an investigator for the National Endowment for the Humanities grant project, “Humanities Connections Curriculum for Medicine, Literature, and Society” (2017–20); and was coprincipal investigator for the Genetics and Human Agency Project, “Intuitions about Genetics and Virtuous Behavior.”
BA, University of Chicago; MPhil, University of Cambridge; MA, PhD, University of Pittsburgh. At Bard since 2019.